Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients With Chronic Heart Failure

Adriaan Alexander Voors, Hans Dirk Düngen, Michele Senni, Savina Nodari, Piergiuseppe Agostoni, Piotr Ponikowski, Jeroen J. Bax, Javed Butler, Raymond J. Kim, Bernard Dorhout, Wilfried Dinh, Mihai Gheorghiade

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients With Chronic Heart Failure'. Together they form a unique fingerprint.

Medicine & Life Sciences